BTIG Reiterates Exact Sciences (EXAS) at Buy, 'tie up between ABT and EXAS makes sense'
Tweet Send to a Friend
BTIG analyst Mark Massaro reiterated a Buy rating and $85.00 price target on Exact Sciences (NASDAQ: EXAS).The analyst commented: "Shares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
